Gurgaon (Haryana) [India], March 14 (ANI/BusinessWire India): Art of Healing Cancer, a leading cancer care provider in India, is pleased to share information on the role of liquid biopsy in the management of cancer. This technique is revolutionising cancer care by providing a non-invasive an
A new weapon in the arsenal of cancer cells' treatment resistance, according to a study conducted by the Garvan Institute of Medical Research, is the ability for them to respond randomly to chemotherapy.
According to recent research led by the Garvan Institute of Medical Research, cancer cells have an inbuilt randomness in their capacity to respond to chemotherapy, which is another weapon in their treatment resistance toolbox.
The University of Technology Sydney researchers have created a novel tool that enables doctors to skip invasive biopsy operations and to track the effectiveness of treatment by detecting and analysing cancer cells from blood samples.
Gurugram (Haryana) [India], February 28 (ANI/BusinessWire India): Art of Healing Cancer, a leading cancer treatment centre in India, is proud to announce its collaboration with Abnoba GmbH, Germany, to launch Mistletoe treatment in India. The collaboration brings together two leading cancer
Researchers from the University of Technology Sydney have created a novel tool that enables doctors to skip invasive biopsy operations and to track the effectiveness of treatment by detecting and analysing cancer cells from blood samples.
In addition to chemotherapy, targeted medications have been created to treat cancer. These medications only impact cancer cells, sparing normal cells. A novel targeted therapy for the treatment of acute myeloid leukaemia is called venetoclax (AML). In Finland, Venetoclax just received market
Gene mutations are the cause of cancer. Tumor suppressors and oncogenes are the two main groups of these altered genes in cancer. Mutations in oncogenes can drive cell proliferation, pushing the gas pedal all the way to the floor, whereas mutations in tumour suppressor genes can cause tumour
Cancer is a disease driven by gene mutations. These mutated genes in cancer fall into two major categories: tumour suppressors and oncogenes. Mutations in tumour suppressor genes can allow tumours to grow unchecked - a case of no brakes - while mutations in oncogenes can activate cell prolif
The disulfidptosis form of cell death, which was previously unknown, is described in a study from the University of Texas MD Anderson Cancer Center that was published today in Nature Cell Biology. This finding may pave the way for fresh cancer treatment options.
A recent study from Cornell University offers a new perspective on how the chemotherapy drug etoposide delays and kills vital enzymes that support the growth of cancer cells.
New Cornell research is providing a fresh view into the ways a common chemotherapy agent, etoposide, stalls and poisons the essential enzymes that allow cancer cells to flourish.